ASTERIAS BIOTHERAPEUTICS INC's ticker is AST and the CUSIP is 04624N107. A total of 62 filers reported holding ASTERIAS BIOTHERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $358,000 | -63.8% | 577,262 | -21.2% | 0.05% | -83.6% |
| Q2 2018 | $988,000 | -6.9% | 732,265 | 0.0% | 0.30% | -14.8% |
| Q1 2018 | $1,061,000 | -35.6% | 732,265 | 0.0% | 0.36% | -34.7% |
| Q4 2017 | $1,647,000 | -33.9% | 732,265 | 0.0% | 0.55% | -40.0% |
| Q3 2017 | $2,490,000 | -4.2% | 732,265 | 0.0% | 0.91% | -11.0% |
| Q2 2017 | $2,600,000 | +4.4% | 732,265 | 0.0% | 1.02% | -1.4% |
| Q1 2017 | $2,490,000 | -26.1% | 732,265 | 0.0% | 1.04% | -30.9% |
| Q4 2016 | $3,368,000 | +8.5% | 732,265 | 0.0% | 1.50% | +14.7% |
| Q3 2016 | $3,105,000 | +3596.4% | 732,265 | +1990.6% | 1.31% | +3443.2% |
| Q2 2016 | $84,000 | – | 35,026 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 3,699,848 | $15,687,000 | 2.68% |
| Northeast Financial Consultants Inc | 732,265 | $3,105,000 | 1.31% |
| WEDBUSH SECURITIES INC | 15,000 | $64,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 148,054 | $628,000 | 0.01% |
| THRIVENT FINANCIAL FOR LUTHERANS | 413,278 | $1,752,000 | 0.01% |
| Virtu KCG Holdings LLC | 72,989 | $309,000 | 0.01% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 35,555 | $151,000 | 0.00% |
| WILLIAMS JONES & ASSOCIATES LLC | 15,100 | $64,000 | 0.00% |
| BlackRock Fund Advisors | 612,231 | $2,596,000 | 0.00% |
| Spot Trading L.L.C | 15,000 | $64,000 | 0.00% |